2024-11-30 10:46:18
CStone announced the global multi-regional registration trial of anti-PD-1 antibody nofazinlimab in combination with lenvatinib as first-line treatment for patients with advanced hepatocellular carcinoma successfully reached the prespecified enrollment ta
Corporate/ 2023-07-24
CStone announced the global multi-region...

SUZHOU,China,March 18,2022--CStone Pharmaceuticals ("CStone",HKEX: 2616),a leading biopharmaceutical company focused on research,d...

ZEPP HEALTH RANKED TOP FIVE IN GLOBAL SMARTWATCH SHIPMENTS IN 2021
Corporate/ 2023-07-24
ZEPP HEALTH RANKED TOP FIVE IN GLOBAL SM...

Global sales continued to excel in Brazil,Turkey,Italy,and the Czech Republic in Q4 2021 CUPERTINO,Calif.,March 18,2022--Zepp Health (NYSE: ...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release